Analyst Ratings for Amedisys (AMED)

AMED Rating Summary

AMED Price Target Summary

* Over Last 12-Mos
  |   Expand Research on AMED
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $235.67 (+42.1%) * Over Last 12-Mos
Rating Score: 5.7 / 10   Percentile Rank: 58%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/10/2021 Cowen Gary Taylor New Coverage Market Perform
(N/A)
195.00
(N/A)
185.08
(165.89)
-10.37% Details
8/5/2021 BofA Securities Joanna Gajuk Downgrade Neutral
(Buy)
220.00
(N/A)
256.27
(165.89)
-35.27% Details
Like AMED Ratings? Also take a look at OPCH, LHCG, OSH, NXGN

AMED Ratings News